Reply to Letter to Editor from Juan-Enrique Schwarze and colleagues - Critical appraisal on "Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France".
- DOI
- 10.1016/j.eurox.2024.100331
- Published
- 2024 Sep
- Container
- European journal of obstetrics & gynecology and reproductive biology: X
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.eurox.2024.100331,
title = {Reply to Letter to Editor from Juan-Enrique Schwarze and colleagues - Critical appraisal on "Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France".},
author = {Lehmann M and Pouly JL and Barrière P and Boland LA and Bean SG and Jenkins J},
year = {2024},
journal = {European journal of obstetrics \& gynecology and reproductive biology: X},
doi = {10.1016/j.eurox.2024.100331},
url = {https://doi.org/10.1016/j.eurox.2024.100331}
}RIS
TY - JOUR TI - Reply to Letter to Editor from Juan-Enrique Schwarze and colleagues - Critical appraisal on "Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France". AU - Lehmann M AU - Pouly JL AU - Barrière P AU - Boland LA AU - Bean SG AU - Jenkins J PY - 2024 JO - European journal of obstetrics & gynecology and reproductive biology: X DO - 10.1016/j.eurox.2024.100331 UR - https://doi.org/10.1016/j.eurox.2024.100331 ER -
APA
M, L., JL, P., P, B., LA, B., SG, B., & J, J. (2024). Reply to Letter to Editor from Juan-Enrique Schwarze and colleagues - Critical appraisal on "Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France".. European journal of obstetrics & gynecology and reproductive biology: X. https://doi.org/10.1016/j.eurox.2024.100331
Source records
- pubmed · retrieved 2026-09-26T23:36:47.148Z